SBC Medical Group Holdings Incorporated Depreciation
SBC Medical Group Holdings Incorporated (SBC) reported Depreciation of $441.39 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-13
- SBC Medical Group Holdings Incorporated depreciation for the quarter ending 2026-06-30 was $441.39K, a 21.76% decline year-over-year.
- SBC Medical Group Holdings Incorporated depreciation for the quarter ending 2026-03-31 was $388.58K, a 35.76% decline year-over-year.
- SBC Medical Group Holdings Incorporated depreciation for the quarter ending 2025-12-31 was $385.15K, a 42.08% decline year-over-year.
- SBC Medical Group Holdings Incorporated depreciation for the quarter ending 2025-09-30 was $452.97K, a 39.26% decline year-over-year.
- SBC Medical Group Holdings Incorporated depreciation for fiscal 2025 was $2.01M, a 26.38% decline from fiscal 2024.
- SBC Medical Group Holdings Incorporated depreciation for fiscal 2024 was $2.73M, a 58.60% decline from fiscal 2023.
- SBC Medical Group Holdings Incorporated depreciation for fiscal 2023 was $6.59M.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $441.39K 10-Q · filed 2026-08-13 | $829.97K 10-Q · filed 2026-08-13 | $1.22M derived: sum of 3 quarters · filed 2026-08-13 | $1.67M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $388.58K 10-Q · filed 2026-05-14 | $773.74K derived: sum of 2 quarters · filed 2026-05-14 | $1.23M derived: sum of 3 quarters · filed 2026-05-14 | $1.79M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $385.15K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $838.12K derived: sum of 2 quarters · filed 2026-03-27 | $1.40M derived: sum of 3 quarters · filed 2026-08-13 | $2.01M 10-K · filed 2026-03-27 |
| 2025-09-30 | $452.97K 10-Q · filed 2025-11-14 | $1.02M derived: sum of 2 quarters · filed 2026-08-13 | $1.62M 10-Q · filed 2025-11-14 | $2.29M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $564.16K 10-Q · filed 2026-08-13 | $1.17M 10-Q · filed 2026-08-13 | $1.83M derived: sum of 3 quarters · filed 2026-08-13 | $2.58M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $604.88K 10-Q · filed 2026-05-14 | $1.27M derived: sum of 2 quarters · filed 2026-05-14 | $2.02M derived: sum of 3 quarters · filed 2026-05-14 | $2.59M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $665.01K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $1.41M derived: sum of 2 quarters · filed 2026-03-27 | $1.98M derived: sum of 3 quarters · filed 2026-03-27 | $2.73M 10-K · filed 2026-03-27 |
| 2024-09-30 | $745.80K 10-Q · filed 2025-11-14 | $1.32M derived: sum of 2 quarters · filed 2025-11-14 | $2.06M 10-Q · filed 2025-11-14 | $3.28M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $570.73K 10-Q · filed 2025-08-13 | $1.32M 10-Q · filed 2025-08-13 | $2.53M derived: sum of 3 quarters · filed 2025-08-13 | $4.43M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $744.81K 10-Q · filed 2025-05-15 | $1.96M derived: sum of 2 quarters · filed 2025-05-15 | $3.86M derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $3.11M derived: sum of 2 quarters · filed 2025-03-28 | $6.59M 10-K · filed 2025-03-28 | |
| 2023-09-30 | $1.90M 10-Q · filed 2024-11-13 | $5.37M 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |